Monday's Health Winners & Losers

Health indices lacked luster Monday, while a few biotech stocks kicked off the week with a swath of regulatory news.

GlaxoSmithKline(GSK Quote) said Monday that the Food and Drug Administration has more questions for the company regarding its cervical cancer vaccine Cervarix before the product can be approved.

The agency's Center for Biologics Evaluation and Research issued Glaxo a "complete response letter" to its Cervarix application, signaling that the review is complete but questions have to be answered before the drug can be approved. Glaxo said it will submit a response to the FDA letter on Cervarix, which is already approved in markets outside the U.S., as soon as possible. ...